Company Filing History:
Years Active: 2008
Title: Annick Arbellot De Vacueur: Innovator in Hyperglycaemia Treatment
Introduction
Annick Arbellot De Vacueur is a notable inventor based in Fontenay Les Briis, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating hyperglycaemia-related pathologies. Her innovative work has the potential to impact the lives of many individuals suffering from these conditions.
Latest Patents
Annick holds a patent for "Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies." This invention relates to compounds of the general formula (I), where R1, R2, X, and A are defined in the claims. These compounds are designed to be effective in the treatment of hyperglycaemia-related pathologies, showcasing her commitment to advancing medical science.
Career Highlights
Annick is associated with Merck Patent Gesellschaft mit beschränkter Haftung, where she continues to work on innovative solutions in the pharmaceutical industry. Her dedication to research and development has positioned her as a key player in her field.
Collaborations
Throughout her career, Annick has collaborated with esteemed colleagues such as Gérard Moinet and Jean-Claude Correc. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Annick Arbellot De Vacueur is a pioneering inventor whose work in developing treatments for hyperglycaemia-related pathologies is commendable. Her contributions to the field of medicinal chemistry reflect her dedication to improving health outcomes for individuals affected by these conditions.